Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial-Reference-Cited by-同舟云学术

Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial

Published:2022-04 Issue:18 Volume:17 Page:1467-1476
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:

Author:

van Geuns Robert-Jan,Chun-Chin Chang,McEntegart Margaret McEntegart,Merkulov Evgeny,Kretov Evgeny,Lesiak Maciej,O’Kane Peter,Hanratty Colm Hanratty,Bressollette Erwan,Silvestri Marc,Wlodarczak Adrian,Barragan Paul,Anderson Richard,Protopopov Aleksey,Peace Aaron,Menown Ian,Rocchiccioli Paul,Onuma Yoshinobu,Oldroyd Keith Oldroyd

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

2. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

3. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

4. Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

5. Vascular responses to a biodegradable polymer (polylactic acid) based Biolimus A9-eluting stent in porcine models

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticagrelor monotherapy after short duration of dual antiplatelet therapy compared to continued dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions: an updated meta-analysis;Coronary Artery Disease;2024-08-23

2. State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan;Cardiovascular Intervention and Therapeutics;2024-07-30

3. Comparison of long-term clinical outcomes of bioabsorbable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis;The Egyptian Heart Journal;2024-07-10

4. Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™;Expert Review of Medical Devices;2024-05-13

5. Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis;Current Cardiology Reports;2023-06-01